Larry Goldenberg

Who is Larry Goldenberg?

S. Larry Goldenberg, CM OBC is an award-winning Canadian researcher in the field of medicine and a pioneer in the treatment of prostate cancer.

Goldenberg is recognized around the world as being one of the first researchers and medical practitioners to compare the practical effectiveness of intermittent androgen suppression as a treatment alternative to continuous hormonal therapy for patients with advanced cases of prostate cancer. His work with IAS has provided the scientific basis for a number of prominent international Phase II and III clinical trials.

Goldenberg spearheaded the clinical development of a low-dose antiandrogen/DES protocol that was among the leading treatment options for advanced prostate cancer until the mid-1990s. He was also one of the co-developers of clinical protocols for the use of neoadjucant hormonal therapy before radical prostatectomy.

Goldenberg's present lab and clinical research undertakings centre on the potential role of MRI in prostate cancer treatments, on the potential uses of focal therapy, and on developing new treatments for benign prostatic hyperplasia.

A world-renowned advocate of patient education, Goldenberg authored one of the first books to explain prostate cancer treatment options in layman's terms. His book, Prostate Cancer: All You Need to Know to Take an Active Part in Your Treatment, now in its third edition, is widely considered to be one of the best resources available to men diagnosed with the disease.